We are live on
!
Find out more
MM
MWG Management Portfolio holdings
AUM
$81.3M
1-Year Est. Return
2.28%
This Fund
S&P 500
This Quarter
Est. Return
-26.28%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
–
AUM
$343M
AUM Growth
-$482M
(-58%)
Cap. Flow
-$322M
Cap. Flow
% of AUM
-93.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
2
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RELX
RELX
|
+$182M |
| 2 |
Illumina
ILMN
|
+$137M |
| 3 |
Lyell Immunopharma
LYEL
|
+$1.52M |
| 4 |
Beam Therapeutics
BEAM
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
Similar funds
BCCM
BPC
AE
BHMP
LMKC
ASM
KDIA
CM
MWG Management's Q4 2021 Portfolio in Review
As of Q4 2021, MWG Management held 4 positions worth $343M, down 58% from $825M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MWG Management withdrew a net $322M in Q4 2021, closing 2 positions and reducing 2 holdings. Its most notable exit was RELX, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 78% a quarter earlier, followed by Industrials.
- MWG Management's biggest Q4 2021 reduction was Lyell Immunopharma, cutting an estimated $1.52M.
- MWG Management fully exited RELX in Q4 2021, selling an estimated $182M.
- MWG Management's ten largest holdings make up 100% of its $343M portfolio in Q4 2021.
- MWG Management opened 0 new positions and closed 2 in Q4 2021.
- MWG Management's portfolio value fell 58% quarter-over-quarter to $343M.
Based on MWG Management's 13F filing for Q4 2021, filed 14 Feb 2022.